Citation Impact
Citing Papers
Anti-Markovnikov alkene oxidation by metal-oxo–mediated enzyme catalysis
2017 StandoutScienceNobel
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Directed Evolution Mimics Allosteric Activation by Stepwise Tuning of the Conformational Ensemble
2018 StandoutNobel
Directed evolution of cytochrome c for carbon–silicon bond formation: Bringing silicon to life
2016 StandoutScienceNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
On the development of new biocatalytic processes for practical pharmaceutical synthesis
2013
Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry
2015 StandoutNobel
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
2012
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus
2012
Cell Culture Systems for Hepatitis C Virus
2013
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Enantioselective Intramolecular CH Amination Catalyzed by Engineered Cytochrome P450 Enzymes In Vitro and In Vivo
2013 StandoutNobel
Elucidating the principles of the molecular organization of heteropolymeric tight junction strands
2011
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
New opportunities for biocatalysis: driving the synthesis of chiral chemicals
2011
Early infection events highlight the limited transmissibility of hepatitis C virus in vitro
2013
Computational Enzyme Design
2013 StandoutNobel
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Receptors and routes of dengue virus entry into the host cells
2015
Enzyme catalysed tandem reactions
2013
Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion
2011
The road to fully programmable protein catalysis
2022 StandoutNatureNobel
Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
2012
Biocatalysis — key to sustainable industrial chemistry
2010
The changing landscape of atherosclerosis
2021 StandoutNature
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
Interacting Regions of CD81 and Two of Its Partners, EWI-2 and EWI-2wint, and Their Effect on Hepatitis C Virus Infection
2011
Expanding the Enzyme Universe: Accessing Non‐Natural Reactions by Mechanism‐Guided Directed Evolution
2015 StandoutNobel
Industrial applications of enzyme biocatalysis: Current status and future aspects
2015
New Generation of Biocatalysts for Organic Synthesis
2014
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
2010
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
2009
The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases
2017
Genetically programmed chiral organoborane synthesis
2017 StandoutNatureNobel
Adaptive Immunity to the Hepatitis C Virus
2010
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies
2013
Enantioselective Enzymes by Computational Design and In Silico Screening
2015 StandoutNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Status of protein engineering for biocatalysts: how to design an industrially useful biocatalyst
2010
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity
2010
The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination
2012
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics
2010
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
2010
Improved Cyclopropanation Activity of Histidine‐Ligated Cytochrome P450 Enables the Enantioselective Formal Synthesis of Levomilnacipran
2014 StandoutNobel
Biocatalytic retrosynthesis
2013
Tip‐Enhanced Raman Spectroscopy of Benzenethiol Adsorbed on Au and Pt Single‐Crystal Surfaces
2004 StandoutNobel
Claudin-1 involved in neonatal ichthyosis sclerosing cholangitis syndrome regulates hepatic paracellular permeability
2011
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Treatment of Chronic Hepatitis C: Current and Future
2013
Engineering the third wave of biocatalysis
2012 StandoutNature
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Occludin Protein Family: Oxidative Stress and Reducing Conditions
2011
Design and evolution of enzymes for non-natural chemistry
2017 StandoutNobel
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies
2014
Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells
2012
Role of Biocatalysis in Sustainable Chemistry
2017
Valorization of Biomass: Deriving More Value from Waste
2012 StandoutScience
Directed Evolution: Bringing New Chemistry to Life
2017 StandoutNobel
Expression of MicroRNA miR-122 Facilitates an Efficient Replication in Nonhepatic Cells upon Infection with Hepatitis C Virus
2012
A Hafnium-Based Metal–Organic Framework as a Nature-Inspired Tandem Reaction Catalyst
2015 StandoutNobel
A Role for CD81 and Hepatitis C Virus in Hepatoma Mobility
2014
Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts
2009
Genetic Optimization of Metalloenzymes: Enhancing Enzymes for Non‐Natural Reactions
2016
Hybridization of MOFs and polymers
2017 StandoutNobel
Hepatitis C Virus Entry
2013
Unexpected Structural Features of the Hepatitis C Virus Envelope Protein 2 Ectodomain
2014
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity
2008
Identification of transferrin receptor 1 as a hepatitis C virus entry factor
2013
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
Structural characterization of CD81–Claudin-1 hepatitis C virus receptor complexes
2011
Optische Nahfeldmikroskopie und -spektroskopie als Werkzeug in der chemischen Analytik
2000
Enantioselective Imidation of Sulfides via Enzyme-Catalyzed Intermolecular Nitrogen-Atom Transfer
2014 StandoutNobel
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
2010
Unlocking Reactivity of TrpB: A General Biocatalytic Platform for Synthesis of Tryptophan Analogues
2017 StandoutNobel
Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
2010
Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization
2009
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles
2011
MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR
2011
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Hepatoma polarization limitsCD 81 and hepatitisC virus dynamics
2012
On the History of Hepatitis C Virus Cell Culture Systems
2013
MicroRNA Regulation of Atherosclerosis
2016
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Chemomimetic Biocatalysis: Exploiting the Synthetic Potential of Cofactor-Dependent Enzymes To Create New Catalysts
2015 StandoutNobel
Utilisation of biomass for sustainable fuels and chemicals: Molecules, methods and metrics
2010
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Virus‐neutralizing antibodies to hepatitis C virus
2013
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
Hepatitis C Virus Induces Epidermal Growth Factor Receptor Activation via CD81 Binding for Viral Internalization and Entry
2012
Constructing Biocatalytic Cascades: In Vitro and in Vivo Approaches to de Novo Multi-Enzyme Pathways
2016
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Industrial biotechnology—the future of green chemistry?
2011
Enantioselective Total Synthesis of Nigelladine A via Late-Stage C–H Oxidation Enabled by an Engineered P450 Enzyme
2017 StandoutNobel
Application of Designed Enzymes in Organic Synthesis
2011
Works of Christopher Davis being referenced
Hepatitis C Virus Infection of Neuroepithelioma Cell Lines
2010
Claudin Association with CD81 Defines Hepatitis C Virus Entry
2010
Inhibition of hepatitis C virus infection by anti‐claudin‐1 antibodies is mediated by neutralization of E2–CD81–Claudin‐1 associations†
2009
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
2009
A green-by-design biocatalytic process for atorvastatin intermediate
2009
In silico directed mutagenesis identifies the CD 81/claudin‐1 hepatitis C virus receptor interface
2012
CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry
2008
Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
2012
Focused ion-beam fabrication of fiber probes with well-defined apertures for use in near-field scanning optical microscopy
1998
58 FINAL RESULTS – RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY, ANTI-VIRAL PROOF-OF-CONCEPT STUDY OF MIRAVIRSEN, AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION
2012